Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling

Abstract Background Phosphatase and tensin homolog (PTEN) loss is associated with tumorigenesis, tumor progression, and therapy resistance in breast cancer. However, the clinical value of PTEN as a biomarker in these patients is controversial. We sought to determine whether the benefit of traditiona...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, Donatella Gambini, Concetta Blundo, Letterio Runza, Stefano Ferrero, Elena Guerini-Rocco, Nicola Fusco
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-10-01
Colecção:	BMC Cancer
Assuntos:	PTEN Hormone receptors Estrogen receptor Progesterone receptor HER2 Breast cancer
Acesso em linha:	https://doi.org/10.1186/s12885-021-08889-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!